Institutional & Family Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Institutional & Family Asset Management's BMY Position: Q2 2024 in Review
Institutional & Family Asset Management increased its Bristol-Myers Squibb (BMY) stake by 60% in Q2 2024, buying an estimated $45.4K and bringing the position to 2,702 shares worth $112K. The position accounts for 0.02% of the portfolio, ranked #183.
Institutional & Family Asset Management first reported a position in BMY in Q1 2018 and has held it in 26 quarters since. The position peaked at $131K in Q1 2022. 2,147 funds tracked by Wall St. Rank hold BMY as of Q2 2024.
- Institutional & Family Asset Management held 2,702 shares of Bristol-Myers Squibb worth $112K as of Q2 2024.
- Institutional & Family Asset Management bought 1,014 Bristol-Myers Squibb shares in Q2 2024, an estimated $45.4K.
- Bristol-Myers Squibb made up 0.02% of Institutional & Family Asset Management's portfolio in Q2 2024, its #183 holding.
- Institutional & Family Asset Management first reported a position in Bristol-Myers Squibb in Q1 2018 and has held it in 26 quarters since.
- Institutional & Family Asset Management's Bristol-Myers Squibb position peaked at $131K in Q1 2022.
- 2,147 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2024.
Based on Institutional & Family Asset Management's 13F filing for Q2 2024, filed 5 Jul 2024.